Contributed equity

12 Months Ended

Jun. 30, 2026

Contributed Equity [Abstract]

Contributed equity

16. Contributed equity

(a) Share capital

		June 30, 2026 Number				June 30, 2026 A$				June 30, 2025 Number				June 30, 2025 A$
Ordinary shares, fully paid			98,006,092				33,547,250				75,765,468				18,986,249

(b) Movements in ordinary share capital

		Date		Issue price A$				Number of shares				A$
Balance at July 1, 2025									75,765,468				18,986,249
Conversion of Class A performance rights		Jul 30 & Nov 7, 2025			--				10,000,000				2,000,000
Placement — tranches at $1.05 (August 2025 raising)		Aug–Oct 2025			1.05				3,930,637				4,127,168
Placement — tranches 1a and 1b at $1.20 (October 2025 raising)		Oct–Nov 2025			1.20				4,979,333				5,975,200
Placement — tranche 2 at $1.20 (approved at the general meeting of January 7, 2026)		Jan 19, 2026			1.20				1,708,527				2,050,231
Options exercised at $0.25, $0.30 and $0.40		Aug 2025 – May 2026			0.25–0.40				1,622,127				486,840
Transfer from the share-based payments reserve on exercise of options					--				--				170,850
Share issue transaction costs					--				--				(249,288	)
Balance at June 30, 2026									98,006,092				33,547,250
Balance at July 1, 2024									67,200,001				11,863,857
Options exercised at $0.25, $0.30 and $0.40		Jul 29, 2024			0.25–0.40				500,000				158,334
Transfer from the share-based payments reserve on exercise of options					--				--				51,517
Placement — tranche 1 at $0.86		Oct 22, 2024			0.86				5,426,616				4,666,878
Placement — tranche 2 at $0.86		Jan 7, 2025			0.86				2,638,851				2,269,399
Share issue transaction costs					--				--				(23,736	)
Balance at June 30, 2025									75,765,468				18,986,249

Amounts recorded differ marginally from the number of shares multiplied by the issue price because of rounding on individual applications. Of the $486,840 consideration received on the exercise of options during the year ended June 30, 2026, $31,424 had been received before July 1, 2025 and was carried forward as application monies; the balance of $455,416 was received during the year and is presented within financing activities in the statement of cash flows.

(c) Share issue transaction costs

Transaction costs of $249,288 (2025: $23,736) directly attributable to the completed equity issues have been deducted from contributed equity (note 1(n)).

(d) Rights attaching to ordinary shares

Ordinary shares entitle the holder to participate in dividends and in the proceeds on winding up of the Company in proportion to the number of, and amounts paid on, the shares held. On a show of hands every holder present in person or by proxy has one vote, and on a poll every holder has one vote for each fully paid ordinary share held. Ordinary shares have no par value and the Company does not have a limited amount of authorised capital.

Shares on issue at June 30, 2026 comprised 84,756,092 quoted ordinary shares and 13,250,000 ordinary shares subject to voluntary escrow, which were released from escrow on July 5, 2026 (note 25). Escrowed shares rank equally with quoted ordinary shares in all respects other than transferability during the escrow period.